Have a personal or library account? Click to login
Tyreoliberin (Trh) – The Regulatory Neuropeptide of Cns Homeostasis Cover

Tyreoliberin (Trh) – The Regulatory Neuropeptide of Cns Homeostasis

Medical Journal of Cell Biology
Volume 2 (2010): Issue 4 (November 2010)
By: Danuta Jantas  
Open Access
|Oct 2014

References

  1. [1] ALKEMADE A, UNMEHOPA UA, WIERSINGA WM, SWAAB DF, FLIERS E. Glucocorticoids decrease thyrotropin-releasing hormone messenger ribonucleic acid expression in the paraventricular nucleus of the human hypothalamus. J Clin Endocrinol Metab. 2005; 90: 323-327.1550964510.1210/jc.2004-1430
    Open DOISearch in Google Scholar
  2. [2] BEHRMANN DL, BRESNAHAN JC, BEATTIE MS. Modeling of acute spinal cord injury in the rat: neuroprotection and enhanced recovery with methylprednisolone, U-74006F and YM-14673. Exp Neurol. 1994; 126: 61-75.10.1006/exnr.1994.1042
    Search in Google Scholar
  3. [3] BIDAUD I, LORY P, NICOLAS P, BULANT M, LADRAM A. Characterization and functional expression of cDNAs encoding thyrotropin-releasing hormone receptor from Xenopus laevis. Eur J Biochem. 2002; 269: 4566-4576.10.1046/j.1432-1033.2002.03152.x
    Search in Google Scholar
  4. [4] BOLER J, ENZMANN F, FOLKERS K, BOWSER CY, SCHALLY AV. The identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyroglutamyl-histidyl-proline amide. Biochem Biophys Res Commun. 1969; 37: 705-710.10.1016/0006-291X(69)90868-74982117
    Open DOISearch in Google Scholar
  5. [5] BORLONGAN CV, STAHL CE, REDEI E, WANG Y. Prepro-thyrotropin-releasing hormone 178-199 exerts partial protection against cerebral ischemia in adult rats. Neuroreport 1999; 10: 3501-3505.10.1097/00001756-199911260-0000710619633
    Search in Google Scholar
  6. [6] BROOKS BR. A summary of the current position of TRH in ALS therapy. Ann N Y Acad Sci. 1989; 553: 431-461.10.1111/j.1749-6632.1989.tb46664.x
    Search in Google Scholar
  7. [7] BURGUS R, DUNN TF, DESIDERO D, GUILLEMIN R. Molecular structure of the hypothalamic hypophysiotropic TRF factor of ovine origin: mass spectrometry demonstration of the PCA-His-Pro- NH2 sequence. C R Acad Sci Hebd Seances Acad Sci D. 1969, 269; 1870-1873.
    Search in Google Scholar
  8. [8] CARROLL AR, LAMB J, MONI R, GUYMER GP, FORSTER PI, QUINN RJ Myrtucommulones FI, phloroglucinols with thyrotropin-releasing hormone receptor-2 binding affinity from the seeds of Corymbia scabrida. J Nat Prod. 2008; 71: 1564-1568.10.1021/np800247u18771320
    Search in Google Scholar
  9. [9] CHIAMOLERA MI, WONDISFORD FE. Minireview: Thyrotropin-releasing hormone and the thyroid hormone feedback mechanism. Endocrinology. 2009; 150: 1091-1096.10.1210/en.2008-179519179434
    Search in Google Scholar
  10. [10] CIOSEK J. Influence of thyroliberin on vasopressin and oxytocin release from the hypothalamoneurohypophysial system under in vivo and in vitro conditions. Postepy Hig Med Dosw. 2007; 61: 429-437.
    Search in Google Scholar
  11. [11] CIOSEK J. Thyrotropin-releasing hormone (TRH): the biosynthesis, distribution, receptors and metabolism. Endokrynologia Polska 2004; 55 (5): 608-615.
    Search in Google Scholar
  12. [12] DENG PY, PORTER JE, SHIN HS, LEI S. Thyrotropin-releasing hormone increases GABA release in rat hippocampus. J Physiol. 2006; 577: 497-511.10.1113/jphysiol.2006.118141189044216990402
    Search in Google Scholar
  13. [13] ENGEL S, GERSHENGORN MC. Thyrotropin-releasing hormone and its receptors--a hypothesis for binding and receptor activation. Pharmacol Ther. 2007; 113: 410-419.10.1016/j.pharmthera.2006.09.00417123625
    Search in Google Scholar
  14. [14] ENGEL S, NEUMANN S, KAUR N, MONGA V, JAIN R, NORTHUP J, GERSHENGORN MC. Low affinity analogs of thyrotropin-releasing hormone are super-agonists. J Biol Chem. 2006; 281: 13103-13109.10.1074/jbc.M600440200
    Search in Google Scholar
  15. [15] FADEN AI, JACOBS TP, HOLADAY JW. Thyrotropin-releasing hormone improves neurologic recovery after spinal trauma in cats. N Engl J Med. 1981; 305: 1063-1067.10.1056/NEJM198110293051806
    Search in Google Scholar
  16. [16] FADEN AI, KNOBLACH SM, CERNAK I, FAN L, VINK R, ARALDI GL, FRICKE ST, ROTH BL, KOZIKOWSKI AP. Novel diketopiperazine enhances motor and cognitive recovery after traumatic brain injury in rats and shows neuroprotection in vitro and in vivo. J Cereb Blood Flow Metab. 2003; 23: 342-354.1262130910.1097/01.WCB.0000046143.31247.FD
    Search in Google Scholar
  17. [17] FADEN AI, KNOBLACH SM, MOVSESYAN VA, LEA PM, CERNAK I. Novel neuroprotective tripeptides and dipeptides. Ann N Y Acad Sci. 2005; 1053: 472-481.10.1196/annals.1344.041
    Search in Google Scholar
  18. [18] FADEN AI, MOVSESYAN VA, KNOBLACH SM, AHMED F, CERNAK I. Neuroprotective effects of novel small peptides in vitro and after brain injury. Neuropharmacology 2005; 49: 410-424.10.1016/j.neuropharm.2005.04.00115907950
    Open DOISearch in Google Scholar
  19. [19] FADEN AI, SACKSEN I, NOBLE LJ. Structure-activity relationships of TRH analogs in rat spinal cord injury. Brain Res. 1988; 448: 287-293.10.1016/0006-8993(88)91265-6
    Search in Google Scholar
  20. [20] FOLTYN W, NOWAKOWSKA-ZAJDEL E, DANIKIEWICZ A, BRODZIAK A. Hypothalamicpituitary- thyroid axis in depression. Psychiatr Pol. 2002; 36: 281-292.
    Search in Google Scholar
  21. [21] GARY KA, SEVARINO KA, YARBROUGH GG, PRANGE AJ Jr, WINOKUR A. The thyrotropinreleasing hormone (TRH) hypothesis of homeostatic regulation: implications for TRH-based therapeutics. J Pharmacol Exp Ther. 2003; 305: 410-416.10.1124/jpet.102.044040
    Search in Google Scholar
  22. [22] GUTIERREZ-MARISCAL M, de GORTARI P, LOPEZ-RUBALCAVA C, MARTINEZ A, JOSEPHBRAVO P. Analysis of the anxiolytic-like effect of TRH and the response of amygdalar TRHergic neurons in anxiety. Psychoneuroendocrinology. 2008; 33: 198-213.10.1016/j.psyneuen.2007.11.002
    Open DOISearch in Google Scholar
  23. [23] HOLLENBERG AN. The role of the thyrotropin-releasing hormone (TRH) neuron as a metabolic sensor. Thyroid. 2008;18: 131-139.1827901310.1089/thy.2007.0251
    Open DOISearch in Google Scholar
  24. [24] JAWORSKA-FEIL L, KAJTA M, BUDZISZEWSKA B, LESKIEWICZ M, LASOŃ W. Protective effects of TRH and its stable analogue, RGH-2202, on kainate-induced seizures and neurotoxicity in rodents. Epilepsy Res. 2001; 43: 67-73.10.1016/S0920-1211(00)00178-9
    Open DOISearch in Google Scholar
  25. [25] JAWORSKA-FEIL, TURCHAN J, PRZEWŁOCKA B, BUDZISZEWSKA B, LEŚKIEWICZ M, LASOŃ W. Effects of pilocarpine- and kainate-induced seizures on thyrotropin-releasing hormone biosynthesis and receptors in the rat brain. J Neural Transm. 1999; 106: 395-407.10.1007/s007020050167
    Search in Google Scholar
  26. [26] JAWORSKA-FEIL, TURCHAN J, PRZEWŁOCKA B, BUDZISZEWSKA B, LEŚKIEWICZ M, LASOŃ W. Effects of pentylenetetrazole-induced kindling on thyrotropin-releasing hormone biosynthesis and receptors in rat brain. Neuroscience 1999; 90: 695-704.1021517110.1016/S0306-4522(98)00446-1
    Search in Google Scholar
  27. [27] KAUR N, MONGA V, LU X, GERSHENGORN MC, JAIN R. Modifications of the pyroglutamic acid and histidine residues in thyrotropin-releasing hormone (TRH) yield analogs with selectivity for TRH receptor type 2 over type 1. Bioorg Med Chem. 2007; 15: 433-443. 10.1016/j.bmc.2006.09.045
    Search in Google Scholar
  28. [28] KREIDER MS, WOLFINGER BL, WINOKUR A. Systemic administration of kainic acid produces elevations in TRH in rat central nervous system. Regul Pept. 1990; 28: 83-93.10.1016/0167-0115(90)90066-62109340
    Open DOISearch in Google Scholar
  29. [29] KUBEK MJ, KNOBLACH SM, SHARIF NA, BURT DR, BUTERBAUGH GG, FUSON KS. Thyrotropin-releasing hormone gene expression and receptors are differentially modified in limbic foci by seizures. Ann Neurol. 1993; 33: 70-76.838819010.1002/ana.410330112
    Open DOISearch in Google Scholar
  30. [30] LASOŃ W. Endogenous anticonvulsant and neuroprotective agents. Przegl Lek. 2004, 61: 1263-1267.
    Search in Google Scholar
  31. [31] LECHAN RM, FEKETE C. The TRH neuron: a hypothalamic integrator of energy metabolism. Prog Brain Res. 2006;153: 209-235.10.1016/S0079-6123(06)53012-2
    Search in Google Scholar
  32. [32] LUO L, STOPA EG. Thyrotropin releasing hormone inhibits tau phosphorylation by dual signaling pathways in hippocampal neurons. J Alzheimers Dis. 2004; 6: 527-536.1550537510.3233/JAD-2004-6510
    Search in Google Scholar
  33. [33] LUO L, YANO N, MAO Q, JACKSON IM, STOPA EG. Thyrotropin releasing hormone (TRH) in the hippocampus of Alzheimer patients. J Alzheimers Dis. 2002; 4: 97-103.1221413310.3233/JAD-2002-420412214133
    Search in Google Scholar
  34. [34] MONGA V, MEENA CL, KAUR N, JAIN R. Chemistry and biology of thyrotropin-releasing hormone (TRH) and its analogs. Curr Med Chem. 2008; 15: 2718-2733.10.2174/0929867087862429121899163218991632
    Open DOISearch in Google Scholar
  35. [35] NIE Y, SCHOEPP DD, KLAUNIG JE, YARD M, LAHIRI DK, KUBEK MJ. Thyrotropin-releasing hormone (protirelin) inhibits potassium-stimulated glutamate and aspartate release from hippocampal slices in vitro. Brain Res. 2005; 1054: 45-54.10.1016/j.brainres.2005.06.07716055093
    Search in Google Scholar
  36. [36] NODA Y, FURUKAWA K, KOHAYAKAWA H, OKA M. Effects of RGH-2202 on behavioral deficits after focal cerebral ischemia in rats. Pharmacol Biochem Behav. 1995; 52: 695-699.858790710.1016/0091-3057(95)00134-I
    Open DOISearch in Google Scholar
  37. [37] OKA M, ITOH Y, UKAI Y, YOSHIKUNI Y, KIMURA K. Protein kinases are involved in prolonged acetylcholine release from rat hippocampus induced by thyrotropin-releasing hormone analogue NS-3. J Neurochem. 1996; 66: 1889-1893.10.1046/j.1471-4159.1996.66051889.x
    Search in Google Scholar
  38. [38] PEKARY AE, SATTIN A, MEYERHOFF JL, CHILINGAR M. Valproate modulates TRH receptor, TRH and TRH-like peptide levels in rat brain. Peptides. 2004; 25: 647-658.10.1016/j.peptides.2004.01.01615165721
    Open DOISearch in Google Scholar
  39. [39] PRZEWŁOCKA B, LABUZ D, MIKA J, LIPKOWSKI A, van LUIJTELAAR G, COENEN A, LASOŃ W. Protective effects of TRH and its analogues in chemical and genetic models of seizures. Pol J Pharmacol. 1997; 49: 373-378.9566039
    Search in Google Scholar
  40. [40] PUNIAK MA, FREEMAN GM, AGRESTA CA, van NEWKIRK L, BARONE CA, SALZMAN SK. Comparison of a serotonin antagonist, opioid antagonist, and TRH analog for the acute treatment of experimental spinal trauma. J Neurotrauma 1991; 8: 193-203.10.1089/neu.1991.8.193
    Open DOISearch in Google Scholar
  41. [41] RAJPUT SK, KRISHNAMOORTHY S, PAWAR C, KAUR N, MONGA V, MEENA CL, JAIN R, SHARMA SS. Antiepileptic potential and behavioral profile of L-pGlu-(2-propyl)-L-His-L-ProNH2, a newer thyrotropin-releasing hormone analog. Epilepsy Behav. 2009; 14: 48-53.10.1016/j.yebeh.2008.10.00618952198
    Open DOISearch in Google Scholar
  42. [42] SATTIN A, PEKARY AE, BLOOD J. Escitalopram regulates expression of TRH and TRH-like peptides in rat brain and peripheral tissues. Neuroendocrinology. 2008; 88: 135-146.10.1159/000121595
    Search in Google Scholar
  43. [43] SATTIN A, SENANAYAKE SS, PEKARY AE. Lithium modulates expression of TRH receptors and TRH-related peptides in rat brain. Neuroscience. 2002; 115: 263-273.10.1016/S0306-4522(02)00373-1
    Search in Google Scholar
  44. [44] SCALABRINO GA, HOGAN N, O'BOYLE KM, SLATOR GR, GREGG DJ, FITCHETT CM, DRAPER SM, BENNETT GW, HINKLE PM, BAUER K, WILLIAMS CH, TIPTON KF, KELLY JA. Discovery of a dual action first-in-class peptide that mimics and enhances CNS-mediated actions of thyrotropin-releasing hormone. Neuropharmacology. 2007; 52: 1472-1481.10.1016/j.neuropharm.2007.02.00317418282
    Open DOISearch in Google Scholar
  45. [45] SCHIOTH HB, PRUSIS P, MUCENIECE R, MUTULIS F, MUTULE I, WIKBERG JE. Thyrotropin releasing hormone (TRH) selectively binds and activates the melanocortin 1 receptor. Peptides. 1999; 20: 395-400.10.1016/S0196-9781(98)00168-510447100
    Open DOISearch in Google Scholar
  46. [46] SUN Y, LU X, GERSHENGORN MC. Thyrotropin-releasing hormone receptors -- similarities and differences. J Mol Endocrinol. 2003; 30: 87-97.10.1677/jme.0.03000871268393312683933
    Open DOISearch in Google Scholar
  47. [47] SUN Y, ZUPAN B, RAAKA BM, TOTH M, GERSHENGORN MC. TRH-Receptor-Type-2- Deficient Mice are Euthyroid and Exhibit Increased Depression and Reduced Anxiety Phenotypes. Neuropsychopharmacology. 2008; Dec 10 [Epub ahead of print].10.1038/npp.2008.217
    Search in Google Scholar
  48. [48] VALASSI E, SCACCHI M, CAVAGNINI F. Neuroendocrine control of food intake. Nutr Metab Cardiovasc Dis. 2008; 18, 158-168.1806141410.1016/j.numecd.2007.06.004
    Open DOISearch in Google Scholar
  49. [49] VERONESI MC, YARD M, JACKSON J, LAHIRI DK, KUBEK MJ. An analog of thyrotropinreleasing hormone (TRH) is neuroprotective against glutamate-induced toxicity in fetal rat hippocampal neurons in vitro. Brain Res. 2007; 1128: 79-85. 10.1016/j.brainres.2006.10.047
    Search in Google Scholar
  50. [50] VETULANI J, NALEPA I. Antidepressants: past, present and future. Eur J Pharmacol. 2000; 405: 351-363.10.1016/S0014-2999(00)00565-3
    Search in Google Scholar
  51. [51] VINK R, McINTHOSH TK, FADEN AI. Treatment with the thyrotropin-releasing hormone analog CG3703 restores magnesium homeostasis following traumatic brain injury in rats. Brain Res. 1988; 460: 184-188.10.1016/0006-8993(88)91221-8
    Search in Google Scholar
  52. [52] WIKBERG JE, MUCENIECE R, MANDRIKA I, PRUSIS P, LINDBLOM J, POST C, SKOTTNER A. New aspects on the melanocortins and their receptors. Pharmacol Res. 2000; 42: 393-420.10.1006/phrs.2000.07251102370211023702
    Open DOISearch in Google Scholar
  53. [53] WITTMANN G. Regulation of hypophysiotrophic corticotrophin-releasing hormone- and thyrotrophin-releasing hormone-synthesising neurones by brainstem catecholaminergic neurones. J Neuroendocrinol. 2008; 20: 952-960.1844512310.1111/j.1365-2826.2008.01748.x18445123
    Open DOISearch in Google Scholar
  54. [54] YANO N, LUO L. Effect of thyrotropin releasing hormone (TRH) on gene expressions in rat pancreas: approach by microarray hybridization. JOP. 2004; 5: 193-204.15254348
    Search in Google Scholar
  55. [55] YARBROUGH GG. Fundamental molecular mechanism of the CNS effects of TRH. Trends Pharmacol Sci. 2003; 24: 617-618.10.1016/j.tips.2003.10.0011465430114654301
    Open DOISearch in Google Scholar
  56. [56] ZENG H, SCHIMPF BA, ROHDE AD, PAVLOVA MN, GRAGEROV A, BERGMANN JE. Thyrotropin-releasing hormone receptor 1-deficient mice display increased depression and anxiety-like behavior. Mol Endocrinol. 2007; 21: 2795-2804. 10.1210/me.2007-004817666589
    Search in Google Scholar
DOI: https://doi.org/10.2478/v10052-010-0008-4 | Journal eISSN: 2544-3577
Journal RSS Feed
Language: English
Page range: 139 - 153
Published on: Oct 15, 2014
Published by: Foundation for Cell Biology and Molecular Biology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
thyreoliberin,
metabolism,
neuromodulator,
nootropic factor,
analepsy,
antidepressant,
neuroprotection
Related subjects:
Life sciences,
Molecular biology,
Biochemistry

© 2014 Danuta Jantas, published by Foundation for Cell Biology and Molecular Biology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 2 (2010): Issue 4 (November 2010)Next article